163 related articles for article (PubMed ID: 9230773)
1. Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992.
Colford JM; Segal M; Tabnak F; Chen M; Sun R; Tager I
Am J Epidemiol; 1997 Jul; 146(2):115-27. PubMed ID: 9230773
[TBL] [Abstract][Full Text] [Related]
2. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
4. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
Lundgren JD; Barton SE; Katlama C; Ledergerber B; González-Lahoz J; Pinching AJ; Proenca R; Hemmer R; Pedersen C; Phillips AN
Arch Intern Med; 1995 Apr; 155(8):822-8. PubMed ID: 7717790
[TBL] [Abstract][Full Text] [Related]
5. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States.
Dworkin MS; Hanson DL; Navin TR
J Infect Dis; 2001 May; 183(9):1409-12. PubMed ID: 11294675
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
10. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
[TBL] [Abstract][Full Text] [Related]
12. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
13. Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression. Pulmonary Complications of HIV Study Group.
Osmond DH; Chin DP; Glassroth J; Kvale PA; Wallace JM; Rosen MJ; Reichman LB; Poole WK; Hopewell PC
Clin Infect Dis; 1999 Sep; 29(3):536-43. PubMed ID: 10530443
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
15. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
Mammen-Tobin A; Monteiro EF
Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
[No Abstract] [Full Text] [Related]
18. [Effect of antiretroviral treatment and prophylaxis for opportunistic infections on survival of patients with AIDS].
Gálvez Hermoso C; Blanco Quintana F; del Amo Valero J; Díez Ruiz-Navarro M; Soriano Vázquez V; González Lahoz J
Rev Clin Esp; 2000 Apr; 200(4):187-92. PubMed ID: 10857401
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia versus wasting syndrome among AIDS cases in Puerto Rico: a survival analysis.
Mayor Becerra AM; Suárez E; Morales Bedoya A
P R Health Sci J; 1996 Dec; 15(4):257-60. PubMed ID: 9097342
[TBL] [Abstract][Full Text] [Related]
20. [Pneumocystis carinii pneumonia in HIV-infected patients examined by bronchoscopy during the period 1989-1991].
Jensen AM; Lundgren JD; Nielsen TL; Benfield TL; Vestbo J
Ugeskr Laeger; 1994 Jul; 156(29):4241-4. PubMed ID: 8066923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
